Onco-Innovations Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 16, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023
Market Capitalization	81	76	-	-
Enterprise Value	80	76	-	-
Last Close Price	1.45	1.50	-	-
PS Ratio	526.65	1164.95	-	-
PB Ratio	45.03	42.13	-	-
P/TBV Ratio	45.03	42.13	-	-
EV/Sales Ratio	-	1158.58	-	-
Asset Turnover	-	0.05	-	-
Quick Ratio	2.32	2.94	3.47	-
Current Ratio	4.40	5.41	3.47	-
Return on Equity (ROE)	-	-799.79%	-233.40%	-
Return on Assets (ROA)	-	-144.12%	-105.54%	-
Return on Capital (ROIC)	-	-180.66%	-145.87%	-
Return on Capital Employed (ROCE)	-371.80%	-170.10%	-123.50%	-1.30%
Earnings Yield	-17.51%	-11.17%	-	-
Buyback Yield / Dilution	-	-905.82%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.